BUZZ-Top of the Street: round-up of highly rated analyst action in Europe
Ratings & estimate changes by Europe's top-ranked* analysts:
** Active Biotech (Other OTC: ATVBF - news) : Goldman Sachs (NYSE: GS-PB - news) initiates with a buy rating, TASQ potential not factored into share price.
** Adidas AG (Other OTC: ADDDF - news) : drops off Credit Suisse Europe focus list, on FX and unhedged exposure to Russia, 4 of 5 analysts since March 5 have EPS estimates for the Mar-14 quarter, average revision -25.8%.
** Lloyds : Numis, 5-star analyst, upgrades to buy, equity cash-flow & steady dividend hikes in 2015, 2016.
** Bunzl (Frankfurt: BUZ1.F - news) : HSBC, 4-star analyst, hikes target price to 1700p, minimal EM exposure & potential for Europe surprises, valuation the key concern, sticks with neutral rating.
** Saint Gobain (Berlin: GOB.BE - news) : Jefferies, 5-star analyst, resumes coverage with a buy rating, target price at 54, on Western Europe & US recovery.
** Amadeus : N+1 Equities, 5 star analyst, upgrades to buy on IHG contract.
** LVMH (TLO: LVMH.TI - news) : Deutsche upgrades to buy, expects stock to play catch-up to sector.
** Thales (Dusseldorf: CSF.DU - news) : JPMorgan, 4-star analyst, reiterates overweight ahead of co's first capital markets day in 4 years. Small upgrade to 2015-2017 EPS estimates.
* Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.
(Stocks Buzz is a pilot project. Please send any feedback or suggestions to vikram.subhedar@thomsonreuters.com) (RM (LSE: RM.L - news) : vikram.subhedar.thomsonreuters.com@reuters.net)